Cardiotoxicity in patients treated with bevacizumab is potentially reversible
- PMID: 21606423
- DOI: 10.1200/JCO.2011.35.5008
Cardiotoxicity in patients treated with bevacizumab is potentially reversible
Comment on
-
Congestive heart failure risk in patients with breast cancer treated with bevacizumab.J Clin Oncol. 2011 Feb 20;29(6):632-8. doi: 10.1200/JCO.2010.31.9129. Epub 2011 Jan 4. J Clin Oncol. 2011. PMID: 21205755
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
